Samir Narayan

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki et al. · The Lancet Oncology · 2015 · 2K citations · Full text

Consolidation Carboplatin, Oncology, Radiation Therapy +6

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial

Stephen G. Chun, Chen Hu, Hak Choy et al. · Journal of Clinical Oncology · 2016 · 715 citations · Full text

Randomized Clinical Trial, Surgical Oncology, Imrt Outcomes +18

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer

Jeffrey D. Bradley, Chen Hu, Ritsuko Komaki et al. · Journal of Clinical Oncology · 2019 · 540 citations · Full text

Quality of Life Analysis of a Radiation Dose–Escalation Study of Patients With Non–Small-Cell Lung Cancer

Benjamin Movsas, Chen Hu, Jeffrey A. Sloan et al. · JAMA Oncology · 2015 · 177 citations · Full text

A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617.

Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki et al. · Journal of Clinical Oncology · 2013 · 150 citations

Radiation Medicine, Radiation Therapy, Treatment Verification +12